制定控股公司
US ˙ NasdaqGS ˙ US29249E1091

介绍

本页面提供了有关 Hafrun Fridriksdottir 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Hafrun Fridriksdottir已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Executive VP, Global R&D 1,387
US:ACT / Enact Holdings, Inc. SVP, GLOBAL R&D 6,914
Sr VP, Global Generics R&D 0
如何解读这些图表

以下图表显示了在Hafrun Fridriksdottir进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

ACT / Enact Holdings, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 ACT / Enact Holdings, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ACT / Enact Holdings, Inc. Insider Trades
ACT / Enact Holdings, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 ACT / Enact Holdings, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ACT / Enact Holdings, Inc. Insider Trades
内幕交易历史

该表格显示了由 Hafrun Fridriksdottir 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2022-05-19 2022-05-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -130,000 1,387 -98.94 8.22 -1,068,067 11,391
2022-03-08 2022-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -8,941 126,087 -6.62 7.37 -65,866 928,842
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -23,764 71,293 -25.00
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 23,764 135,028 21.36
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 140,750 140,750
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -18,905 18,906 -50.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -51,488 0 -100.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,618 111,264 -5.61 7.48 -49,519 832,529
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,905 117,882 19.10
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -18,020 98,977 -15.40 7.48 -134,835 740,592
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 51,488 116,997 78.60
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -21,682 43,366 -33.33
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -7,590 65,509 -10.38 8.14 -61,799 533,383
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 21,682 73,099 42.17
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -16,121 0 -100.00
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,116 51,417 -10.63 9.06 -55,412 465,844
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 16,121 57,533 38.93
2022-02-10 2022-02-08 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 51,488 51,488
2021-08-12 2021-08-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -50,860 41,412 -55.12 9.95 -506,021 412,016
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -37,884 0 -100.00
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -19,066 92,272 -17.12 10.22 -194,830 942,895
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 37,884 111,338 51.58
2021-03-08 2021-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 95,057 95,057
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -18,905 37,811 -33.33
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,515 73,454 -11.47 10.57 -100,536 776,117
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 18,905 82,969 29.51
2021-03-04 2021-03-02 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -50,000 64,064 -43.84 10.82 -540,890 693,026
2021-03-02 2021-03-01 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -10,912 114,064 -8.73 10.83 -118,186 1,235,399
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -21,682 65,048 -25.00
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 21,682 124,976 20.99
2021-02-17 2021-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,098 103,294 -1.99 11.12 -23,336 1,148,923
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -5,355 0 -100.00
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 5,355 105,392 5.35
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,884 37,884
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -16,120 16,121 -50.00
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -23,639 100,037 -19.11 12.69 -300,085 1,269,914
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -5,857 123,676 -4.52 12.69 -74,352 1,569,999
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
A - Award 67,852 129,533 110.01
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 16,120 61,681 35.38
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -266 0 -100.00
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -748 0 -100.00
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -134 45,561 -0.29 7.16 -960 326,373
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -380 45,695 -0.82 7.16 -2,722 327,333
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 266 46,075 0.58
2020-03-19 2020-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 748 45,809 1.66
2020-03-03 2020-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 86,730 86,730
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -17,850 0 -100.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -5,353 5,355 -49.99
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -8,825 45,061 -16.38 12.14 -107,155 547,134
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,647 53,886 -4.68 12.14 -32,140 654,289
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 17,850 56,533 46.14
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 5,353 38,683 16.06
2020-02-13 2020-02-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 17,850 17,850
2020-02-11 2020-02-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -5,544 33,330 -14.26 12.27 -68,025 408,953
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -16,120 32,241 -33.33
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 16,120 38,874 70.85
2020-01-02 2019-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -4,640 0 -100.00
2020-01-02 2019-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,459 22,754 -9.75 9.92 -24,396 225,742
2020-01-02 2019-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 4,640 25,213 22.55
2019-12-03 2019-12-02 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -4,310 20,573 -17.32 10.49 -45,214 215,818
2019-12-03 2019-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -8,133 0 -100.00
2019-12-03 2019-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 8,133 24,883 48.56
2019-03-19 2019-03-18 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -93 16,750 -0.55 16.63 -1,546 278,462
2019-03-19 2019-03-18 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -263 16,843 -1.54 16.63 -4,372 280,008
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -265 266 -49.91
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -747 748 -49.97
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 265 17,106 1.57
2019-03-19 2019-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 747 16,841 4.64
2019-03-06 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 56,716 56,716
2019-03-05 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -1,165 0 -100.00
2019-03-05 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -409 16,094 -2.48 16.88 -6,905 271,712
2019-03-05 2019-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 1,165 16,503 7.60
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -5,353 10,708 -33.33
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,841 15,338 -10.72 17.67 -32,529 270,999
2019-02-19 2019-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 5,353 17,179 45.27
2019-01-03 2019-01-02 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,643 11,826 -12.20 15.70 -25,799 185,690
2019-01-03 2018-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -4,640 4,640 -50.00
2019-01-03 2018-12-31 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 4,640 13,469 52.56
2018-12-04 2018-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -2,711 8,133 -25.00
2018-12-04 2018-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -933 8,829 -9.56 21.76 -20,304 192,127
2018-12-04 2018-11-30 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 2,711 9,762 38.45
2018-03-20 2018-03-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -91 7,051 -1.27 17.88 -1,627 126,049
2018-03-20 2018-03-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -257 7,142 -3.47 17.88 -4,595 127,676
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -265 531 -33.29
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -747 1,495 -33.32
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 265 7,399 3.71
2018-03-20 2018-03-17 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 747 7,134 11.70
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,432 0 -100.00
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
F - Taxes -1,155 6,387 -15.32 19.38 -22,384 123,771
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
F - Taxes -400 7,542 -5.04 19.38 -7,752 146,155
2018-03-06 2018-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,432 7,942 76.11
2018-03-06 2018-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -1,165 1,165 -50.00
2018-03-06 2018-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 1,165 4,510 34.83
2018-03-06 3/A TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
3,345
2018-02-12 2018-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 48,361 48,361
2018-02-12 2018-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Stock Options (right to buy)
A - Award 123,288 123,288
2018-01-08 3/A TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
3,342
2018-01-02 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
6,692
2018-01-02 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
6,692
2014-05-13 2014-05-09 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 1,269 6,914 22.48 197.05 250,056 1,362,404
2013-10-03 2013-10-01 4 ACT Actavis plc
Ordinary Shares
A - Award 5,645 5,645
2013-10-02 2013-10-01 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
D - Sale to Issuer -5,645 0 -100.00
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Restricted Stock Units
M - Exercise -5,110 0 -100.00
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
F - Taxes -5,510 5,645 -49.39 144.00 -793,440 812,880
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
M - Exercise 5,110 11,155 84.53
2013-10-02 2013-09-30 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
A - Award 4,318 6,045 250.03
2013-10-02 2012-12-05 4 ACT Actavis, Inc.
Restricted Stock Units
A - Award 5,110 5,110
2013-03-08 2013-03-06 4 ACT Actavis, Inc.
Common Stock, par value $0.0033
A - Award 1,727 1,727
2012-11-05 3 WPI WATSON PHARMACEUTICALS INC
No securities beneficially owned
0
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)